Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant

被引:31
作者
Akache, Bassel [1 ]
Renner, Tyler M. [1 ]
Tran, Anh [1 ]
Deschatelets, Lise [1 ]
Dudani, Renu [1 ]
Harrison, Blair A. [1 ]
Duque, Diana [1 ]
Haukenfrers, Julie [1 ]
Rossotti, Martin A. [1 ]
Gaudreault, Francis [1 ]
Hemraz, Usha D. [2 ]
Lam, Edmond [2 ]
Regnier, Sophie [2 ]
Chen, Wangxue [1 ]
Gervais, Christian [1 ]
Stuible, Matthew [1 ]
Krishnan, Lakshmi [1 ]
Durocher, Yves [1 ]
McCluskie, Michael J. [1 ]
机构
[1] Natl Res Council Canada, Human Hlth Therapeut, 1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada
[2] Natl Res Council Canada, Aquat & Crop Resource Dev, 6100 Ave Royalmount, Montreal, PQ H4P 2R2, Canada
关键词
PROTEIN; NEUTRALIZATION; CHALLENGES; COVID-19; VECTORS; COV;
D O I
10.1038/s41598-021-01363-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The huge worldwide demand for vaccines targeting SARS-CoV-2 has necessitated the continued development of novel improved formulations capable of reducing the burden of the COVID-19 pandemic. Herein, we evaluated novel protein subunit vaccine formulations containing a resistin-trimerized spike antigen, SmT1. When combined with sulfated lactosyl archaeol (SLA) archaeosome adjuvant, formulations induced robust antigen-specific humoral and cellular immune responses in mice. Antibodies had strong neutralizing activity, preventing viral spike binding and viral infection. In addition, the formulations were highly efficacious in a hamster challenge model reducing viral load and body weight loss even after a single vaccination. The antigen-specific antibodies generated by our vaccine formulations had stronger neutralizing activity than human convalescent plasma, neutralizing the spike proteins of the B.1.1.7 and B.1.351 variants of concern. As such, our SmT1 antigen along with SLA archaeosome adjuvant comprise a promising platform for the development of efficacious protein subunit vaccine formulations for SARS-CoV-2.
引用
收藏
页数:17
相关论文
共 63 条
[1]   A simple protein-based surrogate neutralization assay for SARS-CoV-2 [J].
Abe, Kento T. ;
Li, Zhijie ;
Samson, Reuben ;
Samavarchi-Tehrani, Payman ;
Valcourt, Emelissa J. ;
Wood, Heidi ;
Budylowski, Patrick ;
Dupuis, Alan P. ;
Girardin, Roxie C. ;
Rathod, Bhavisha ;
Wang, Jenny H. ;
Barrios-Rodiles, Miriam ;
Colwill, Karen ;
McGeer, Allison J. ;
Mubareka, Samira ;
Gommerman, Jennifer L. ;
Durocher, Yves ;
Ostrowski, Mario ;
McDonough, Kathleen A. ;
Drebot, Michael A. ;
Drews, Steven J. ;
Rini, James M. ;
Gingras, Anne-Claude .
JCI INSIGHT, 2020, 5 (19)
[2]   Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model [J].
Akache, Bassel ;
Agbayani, Gerard ;
Stark, Felicity C. ;
Jia, Yimei ;
Dudani, Renu ;
Harrison, Blair A. ;
Deschatelets, Lise ;
Chandan, Vandana ;
Lam, Edmond ;
Hemraz, Usha D. ;
Regnier, Sophie ;
Krishnan, Lakshmi ;
McCluskie, Michael J. .
PHARMACEUTICS, 2021, 13 (02) :1-12
[3]   Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins [J].
Akache, Bassel ;
Deschatelets, Lise ;
Harrison, Blair A. ;
Dudani, Renu ;
Stark, Felicity C. ;
Jia, Yimei ;
Landi, Amir ;
Law, John L. M. ;
Logan, Michael ;
Hockman, Darren ;
Kundu, Juthika ;
Tyrrell, D. Lorne ;
Krishnan, Lakshmi ;
Houghton, Michael ;
McCluskie, Michael J. .
VACCINES, 2019, 7 (04)
[4]   Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice [J].
Akache, Bassel ;
Stark, Felicity C. ;
Jia, Yimei ;
Deschatelets, Lise ;
Dudani, Renu ;
Harrison, Blair A. ;
Agbayani, Gerard ;
Williams, Dean ;
Jamshidi, Mohammad P. ;
Krishnan, Lakshmi ;
McCluskie, Michael J. .
PLOS ONE, 2018, 13 (12)
[5]   Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants [J].
Akache, Bassel ;
Stark, Felicity C. ;
Iqbal, Umar ;
Chen, Wangxue ;
Jia, Yimei ;
Krishnan, Lakshmi ;
McCluskie, Michael J. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) :1746-1759
[6]   Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model [J].
Amanat, Fatima ;
Strohmeier, Shirin ;
Rathnasinghe, Raveen ;
Schotsaert, Michael ;
Coughlan, Lynda ;
Garcia-Sastre, Adolfo ;
Krammer, Florian .
MBIO, 2021, 12 (02) :1-10
[7]   Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults [J].
Anderson, E. J. ;
Rouphael, N. G. ;
Widge, A. T. ;
Jackson, L. A. ;
Roberts, P. C. ;
Makhene, M. ;
Chappell, J. D. ;
Denison, M. R. ;
Stevens, L. J. ;
Pruijssers, A. J. ;
McDermott, A. B. ;
Flach, B. ;
Lin, B. C. ;
Doria-Rose, N. A. ;
O'Dell, S. ;
Schmidt, S. D. ;
Corbett, K. S. ;
Swanson, P. A., II ;
Padilla, M. ;
Neuzil, K. M. ;
Bennett, H. ;
Leav, B. ;
Makowski, M. ;
Albert, J. ;
Cross, K. ;
Edara, V. V. ;
Floyd, K. ;
Suthar, M. S. ;
Martinez, D. R. ;
Baric, R. ;
Buchanan, W. ;
Luke, C. J. ;
Phadke, V. K. ;
Rostad, C. A. ;
Ledgerwood, J. E. ;
Graham, B. S. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25) :2427-2438
[8]   Adjuvanting a subunit COVID-19 vaccine to induce protective immunity [J].
Arunachalam, Prabhu S. ;
Walls, Alexandra C. ;
Golden, Nadia ;
Atyeo, Caroline ;
Fischinger, Stephanie ;
Li, Chunfeng ;
Aye, Pyone ;
Navarro, Mary Jane ;
Lai, Lilin ;
Edara, Venkata Viswanadh ;
Roltgen, Katharina ;
Rogers, Kenneth ;
Shirreff, Lisa ;
Ferrell, Douglas E. ;
Wrenn, Samuel ;
Pettie, Deleah ;
Kraft, John C. ;
Miranda, Marcos C. ;
Kepl, Elizabeth ;
Sydeman, Claire ;
Brunette, Natalie ;
Murphy, Michael ;
Fiala, Brooke ;
Carter, Lauren ;
White, Alexander G. ;
Trisal, Meera ;
Hsieh, Ching-Lin ;
Russell-Lodrigue, Kasi ;
Monjure, Christopher ;
Dufour, Jason ;
Spencer, Skye ;
Doyle-Meyers, Lara ;
Bohm, Rudolph P. ;
Maness, Nicholas J. ;
Roy, Chad ;
Plante, Jessica A. ;
Plante, Kenneth S. ;
Zhu, Alex ;
Gorman, Matthew J. ;
Shin, Sally ;
Shen, Xiaoying ;
Fontenot, Jane ;
Gupta, Shakti ;
O'Hagan, Derek T. ;
Van Der Most, Robbert ;
Rappuoli, Rino ;
Coffman, Robert L. ;
Novack, David ;
McLellan, Jason S. ;
Subramaniam, Shankar .
NATURE, 2021, 594 (7862) :253-+
[9]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[10]  
Castells MC, 2021, NEW ENGL J MED, V384, P643, DOI [10.1056/NEJMra2035343, 10.1056/NEJMc2100766]